Oligonucleotide N3'→P5' phosphoramidates as potential therapeutic agents

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1489, Issue 1, 1999, Pages 131-140

  Gryaznov, Sergei M ^a  

^a GERON CORPORATION   (United States)

Author keywords

Antigene; Antisense; Duplex; Oligonucleotide phosphoramidate; Triplex

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; PHOSPHORAMIDIC ACID DERIVATIVE; AMIDE; DNA; MESSENGER RNA; MYC PROTEIN; ONCOPROTEIN; PHOSPHORAMIDIC ACID; PHOSPHORIC ACID;

DRUG ACTIVITY; DRUG STRUCTURE; GENE EXPRESSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL DIVISION; CELL LINE; CHEMISTRY; CONFORMATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; ENZYME SPECIFICITY; EXPERIMENTAL LEUKEMIA; GENETICS; HUMAN; MOLECULAR MIMICRY; MOUSE; PATHOLOGY; SURVIVAL RATE;

AMIDES; ANIMALS; CELL DIVISION; CELL LINE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; GENE EXPRESSION; HUMANS; LEUKEMIA, EXPERIMENTAL; MICE; MOLECULAR MIMICRY; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENE PROTEINS, FUSION; PHOSPHORIC ACIDS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SUBSTRATE SPECIFICITY; SURVIVAL RATE;

EID: 0033544603     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(99)00151-7     Document Type: Review

References (28)

1. Helene C., Toulme J.-J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta. 1049:1990;99-125.
2. Uhlmann E., Peyman A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 90:1990;543-584.
3. Christoffersen R.E., Marr J.J. Ribozymes as human therapeutic agents. J. Med. Chem. 38:1995;2023-2037.
4. Santoro S.W., Joyce G.F. A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. USA. 94:1997;4262-4266.
5. Unrau P.J., Bartel D.P. RNA-catalysed nucleotide synthesis. Nature. 395:1998;260-263.
6. Pagratis N.C., Bell C., Chang Y.-F., Jennings S., Fitzwater T., Jellinek D., Dang C. Potent 2′-amino- and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat. Biotechnol. 15:1997;68-73.
7. Gryaznov S., Chen J.-K. Oligodeoxyribonucleotide N3′→P5′ phosphoramidates: synthesis and hybridization properties. J. Am. Chem. Soc. 116:1994;3143-3144.
8. Gryaznov S.M., Lloyd D.H., Chen J.-K., Schultz R.G., DeDionisio L.A., Ratmeyer L., Wilson W.D. Oligonucleotide N3′→P5′ phosphoramidates. Proc. Natl. Acad. Sci. USA. 92:1995;5798-5802.
9. Schultz R.G., Gryaznov S.M. Oligo-2′-fluoro-2′-deoxynucleotide N3′→P5′ phosphoramidates: synthesis and properties. Nucleic Acids Res. 24:1996;2966-2973.
10. Gryaznov S.M., Winter H. RNA mimetics: oligoribonucleotide N3′→P5′ phosphoramidates. Nucleic Acids Res. 26:1998;4160-4167.
11. Chen J.-K., Schultz R.G., Lloyd D.H., Gryaznov S.M. Synthesis of oligodeoxyribonucleotide N3′→P5′ phosphoramidates. Nucleic Acids Res. 23:1995;2661-2668.
12. Gryaznov S.M. Synthesis and properties of the oligonucleotide N3′→P5′ phosphoramidates. Nucleosides Nucleotides. 16:1997;899-905.
13. Ding D., Gryaznov S.M., Lloyd D.H., Chandrasekaran S., Yao S., Ratmeyer L., Pan Y., Wilson W.D. An oligodeoxyribonucleotide N3′→P5′ phosphoramidate duplex forms an A-type helix in solution. Nucleic Acids Res. 24:1996;354-360.
14. Ding D., Gryaznov S.M., Wilson W.D. NMR solution structure of the N3′→P5′ phosphoramidate duplex d(CGCGAATTCGCG) by iterative relaxation matrix approach. Biochemistry. 37:1998;12083-12093.
15. Tereshko V., Gryaznov S., Egli M. Consequences of replacing the DNA 3′-oxygen by an amino group: high-resolution crystal structure of a fully modified N3′→P5′ phosphoramidate DNA dodecamer duplex. J. Am. Chem. Soc. 120:1998;269-283.
16. Rigl C.T., Lloyd D.H., Tsou D.S., Gryaznov S.M., Wilson W.D. Structural RNA mimetics: N3′P5′ phosphoramidate DNA analogs of HIV-1 Rre and TAR RNA form A-type helices that bind specifically to Rev- and Tat-related peptides. Biochemistry. 36:1997;650-659.
17. Escude C., Giovannangeli C., Sun J.-S., Lloyd D.H., Chen J.-K., Gryaznov S.M., Garestier T., Helene C. Stable triple helices formed by oligonucleotide N3′→P5′ phosphoramidates inhibit transcription elongation. Pros. Natl. Acad. Sci. USA. 93:1996;4365-4369.
18. Giovannangeli C., Perrouault L., Escude C., Gryaznov S., Helene C. Efficient inhibition of transcription elongation in vitro by oligonucleotide phosphoramidates targeted to proviral HIV DNA. J. Mol. Biol. 26:1996;386-398.
19. Giovannangeli C., Diviacco S., Labrousse V., Gryaznov S., Charneau P., Helene C. Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target. Proc. Natl. Acad. Sci. USA. 94:1997;79-84.
20. Zhou-Sun B.-W., Sun J.-S., Gryaznov S.M., Liquier J., Garestier T., Helene C., Taillandier E. A physico-chemical study of triple helix formation by an oligothymidylate with N3′→P5′ phosphoramidate linkages. Nucleic Acids Res. 25:1997;1782-1787.
21. Roberts R.W., Crothers D.M. Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition. Science. 258:1992;1463-1466.
22. Shimizu M., Konishi A., Shimada Y., Inoue H., Ohtsuka E. Oligo(2′-O-methyl)ribonucleosides. Effective probes for duplex DNA. FEBS Lett. 302:1992;155-158.
23. Guschlbauer W., Jankowski K. Nucleoside conformation is determined by the electronegativity of the sugar substituent. Nucleic Acids Res. 8:1980;1421-1433.
24. Semerad, L.J. Maher III, Exclusion of RNA strand from a purine motif triple helix, Nucleic Acids Res. 22 (1994) 5321-5325.
25. Gryaznov S., Skorski T., Cucco C., Nieborowska-Skorska M., Chiu C.Y., Lloyd D., Chen J.-K., Koziolkiewicz M., Calabretta B. Oligonucleotide N3′→P5′ phosphoramidates as antisense agents. Nucleic Acids Res. 24:1996;1508-1514.
26. DeDionisio L., Gryaznov S.M. Analysis of a ribonuclease H digestion of N3′→P5′ phosphoramidate-RNA duplexes by capillary gel electrophoresis. J. Chromatogr. B 669:1995;125-131.
27. Heidenreich O., Gryaznov S., Nerenberg M. RNase H independent antisense activity of oligonucleotide N3′→P5′ phosphoramidates. Nucleic Acids Res. 25:1997;776-780.
28. Skorski T., Perrotti D., Nieborowska-Skorska M., Gryaznov S., Calabretta B. Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo. Proc. Natl. Acad. Sci. USA. 94:1997;3966-3971.